Market Cap 7.76M
Revenue (ttm) 0.00
Net Income (ttm) -7.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 46,049
Avg Vol 378,774
Day's Range N/A - N/A
Shares Out 12.85M
Stochastic %K 40%
Beta 0.64
Analysts Sell
Price Target $34.00

Company Profile

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 3 933 3121
Fax: 972 3 509 7196
Address:
4 Oppenheimer Street, Science Park, Rehovot, Israel
Stocktelligence
Stocktelligence Feb. 3 at 9:12 PM
$PPBT this feels like purple
1 · Reply
Demon7
Demon7 Feb. 3 at 8:21 PM
$PPBT Got my loss statement today from this stock. Did anything change ?
1 · Reply
Purplepayday
Purplepayday Feb. 3 at 7:47 PM
$PPBT Maybe this is just Fact and not FUD 🤔 We have always had a high percentage Dark Pool trading here Smitty…. And share price have always been declining, so i’m more leaning to this: High-percentage Dark Pool trading can consist of or include significant short-selling activity. Institutional investors and market makers often use these private, off-exchange venues to execute large, bearish positions without immediately causing price drops in public markets.
1 · Reply
Smittysixty
Smittysixty Feb. 3 at 7:19 PM
$PPBT 👀 ⬇️ Who's accumulating? Maybe the volume in Q4 was a distraction. I think we're seeing quiet accumulation RIGHT NOW. https://chartexchange.com/symbol/nasdaq-ppbt/exchange-volume/
0 · Reply
Smittysixty
Smittysixty Feb. 3 at 7:15 PM
$PPBT Another 70% darkpool volume day. The facts are hard to deny. "What 70% Dark Pool Volume Usually Means 1. Institutions Are Accumulating Quietly When dark pool percentage jumps well above a stock's baseline, it often reflects: • Funds building a position without moving the price • Market makers filling institutional orders internally • Accumulation ahead of a catalyst"
0 · Reply
Winorbust
Winorbust Feb. 3 at 6:49 PM
$PPBT I have to reshare this one because this just made me laugh so hard. @Purplepayday A whopping $210 position Hahaha and they are also losing on the position as well. Is this the tute that Smitty is hyping up?
0 · Reply
demo1one
demo1one Feb. 3 at 4:13 PM
$PPBT buy more goyim
0 · Reply
Purplepayday
Purplepayday Feb. 3 at 1:19 PM
$PPBT Smitty was right 🙏✅ Institutions is loading up with 1500% WOW 🚀
1 · Reply
nebleros
nebleros Feb. 2 at 9:34 PM
$PPBT Would it not be great BP following Smitty's lead..
1 · Reply
Smittysixty
Smittysixty Feb. 2 at 9:27 PM
$PPBT The Non‑Pipeline Signals Are Just as Loud Beyond the science, $PPBT has a stack of classic pre‑M&A signals lining up: • Cash runway forces a decision point — partner, raise, or sell • Management bought shares at these levels, aligning them with a takeout outcome • Investigator‑funded Phase 2 reduces burn and provides independent validation • Strategic silence around late‑cohort NT‑219 data • Three assets at three different value‑inflection stages • Institutional holders already positioned These are the same operational signals that tend to show up right before a company enters a transaction window.
0 · Reply
Latest News on PPBT
Purple Biotech Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 7:00 AM EDT - 6 months ago

Purple Biotech Reports Second Quarter 2025 Financial Results


Purple Biotech Reports First Quarter 2025 Financial Results

May 21, 2025, 7:10 AM EDT - 9 months ago

Purple Biotech Reports First Quarter 2025 Financial Results


Purple Biotech Appoints Shai Lankry as Chief Financial Officer

May 12, 2025, 7:30 AM EDT - 9 months ago

Purple Biotech Appoints Shai Lankry as Chief Financial Officer


Why Is Purple Biotech Stock Trading Higher On Monday?

Dec 2, 2024, 9:18 AM EST - 1 year ago

Why Is Purple Biotech Stock Trading Higher On Monday?


Purple Biotech Reports Third Quarter 2024 Financial Results

Nov 15, 2024, 7:00 AM EST - 1 year ago

Purple Biotech Reports Third Quarter 2024 Financial Results


Purple Biotech Reports First Quarter 2024 Financial Results

May 21, 2024, 7:30 AM EDT - 1 year ago

Purple Biotech Reports First Quarter 2024 Financial Results


Purple Biotech Reaches Recommended Phase 2 Dose for NT219

Feb 1, 2024, 7:30 AM EST - 2 years ago

Purple Biotech Reaches Recommended Phase 2 Dose for NT219


Purple Biotech Reports Third Quarter 2023 Financial Results

Nov 21, 2023, 6:50 AM EST - 2 years ago

Purple Biotech Reports Third Quarter 2023 Financial Results


Purple Biotech Announces $5 Million Registered Direct Offering

Oct 17, 2023, 8:00 AM EDT - 2 years ago

Purple Biotech Announces $5 Million Registered Direct Offering


Purple Biotech Reports Second Quarter 2023 Financial Results

Aug 22, 2023, 9:29 AM EDT - 2 years ago

Purple Biotech Reports Second Quarter 2023 Financial Results


Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron

Mar 24, 2023, 7:00 AM EDT - 3 years ago

Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron


Stocktelligence
Stocktelligence Feb. 3 at 9:12 PM
$PPBT this feels like purple
1 · Reply
Demon7
Demon7 Feb. 3 at 8:21 PM
$PPBT Got my loss statement today from this stock. Did anything change ?
1 · Reply
Purplepayday
Purplepayday Feb. 3 at 7:47 PM
$PPBT Maybe this is just Fact and not FUD 🤔 We have always had a high percentage Dark Pool trading here Smitty…. And share price have always been declining, so i’m more leaning to this: High-percentage Dark Pool trading can consist of or include significant short-selling activity. Institutional investors and market makers often use these private, off-exchange venues to execute large, bearish positions without immediately causing price drops in public markets.
1 · Reply
Smittysixty
Smittysixty Feb. 3 at 7:19 PM
$PPBT 👀 ⬇️ Who's accumulating? Maybe the volume in Q4 was a distraction. I think we're seeing quiet accumulation RIGHT NOW. https://chartexchange.com/symbol/nasdaq-ppbt/exchange-volume/
0 · Reply
Smittysixty
Smittysixty Feb. 3 at 7:15 PM
$PPBT Another 70% darkpool volume day. The facts are hard to deny. "What 70% Dark Pool Volume Usually Means 1. Institutions Are Accumulating Quietly When dark pool percentage jumps well above a stock's baseline, it often reflects: • Funds building a position without moving the price • Market makers filling institutional orders internally • Accumulation ahead of a catalyst"
0 · Reply
Winorbust
Winorbust Feb. 3 at 6:49 PM
$PPBT I have to reshare this one because this just made me laugh so hard. @Purplepayday A whopping $210 position Hahaha and they are also losing on the position as well. Is this the tute that Smitty is hyping up?
0 · Reply
demo1one
demo1one Feb. 3 at 4:13 PM
$PPBT buy more goyim
0 · Reply
Purplepayday
Purplepayday Feb. 3 at 1:19 PM
$PPBT Smitty was right 🙏✅ Institutions is loading up with 1500% WOW 🚀
1 · Reply
nebleros
nebleros Feb. 2 at 9:34 PM
$PPBT Would it not be great BP following Smitty's lead..
1 · Reply
Smittysixty
Smittysixty Feb. 2 at 9:27 PM
$PPBT The Non‑Pipeline Signals Are Just as Loud Beyond the science, $PPBT has a stack of classic pre‑M&A signals lining up: • Cash runway forces a decision point — partner, raise, or sell • Management bought shares at these levels, aligning them with a takeout outcome • Investigator‑funded Phase 2 reduces burn and provides independent validation • Strategic silence around late‑cohort NT‑219 data • Three assets at three different value‑inflection stages • Institutional holders already positioned These are the same operational signals that tend to show up right before a company enters a transaction window.
0 · Reply
Winorbust
Winorbust Feb. 2 at 9:08 PM
$PPBT our exec looks like someone who wants to rob shareholders. No wonder he has been arrested before.
1 · Reply
Smittysixty
Smittysixty Feb. 2 at 8:55 PM
$PPBT IM1240: IND‑Ready & Perfectly Timed IM1240 is sitting at the exact stage where early acquisitions happen: • IND‑ready • Clean toxicology • GMP manufacturing complete • Next‑gen T‑cell + NK‑cell activation design Why this is a buyer magnet: Pharma is scooping up IND‑ready immunotherapy platforms before Phase 1 costs hit. It’s cheaper, faster, and gives them full control over development. IM1240 is literally at the front door of Phase 1 — the sweet spot for early‑stage platform M&A.
0 · Reply
Smittysixty
Smittysixty Feb. 2 at 8:54 PM
$PPBT CM24: Randomized Survival Data in Hand CM24 already hit a major de‑risking milestone: • Completed randomized Phase 2 survival study • Targets CEACAM1 — a hot immunotherapy resistance pathway • Combo‑ready with PD‑1 Why this is M&A territory: Randomized survival data is where pharma evaluates: • combo potential • label expansion • whether to take it into Phase 3 (which they usually fund) PB can’t run a Phase 2b or 3 alone — which makes CM24 a prime candidate for a partner or buyer who wants a late‑stage immunotherapy asset.
0 · Reply
Smittysixty
Smittysixty Feb. 2 at 8:53 PM
$PPBT NT‑219: Phase 2 & Deal‑Ready NT‑219 is exactly where Big Pharma likes to step in. • Active investigator‑funded Phase 2 • Recruiting since June • Prior human data already showed tumor shrinkage + PD‑1 re‑sensitization • 100mg cohort completed Why this screams M&A: Phase 2 proof‑of‑mechanism is the classic acquisition window. Investigator‑funded = independent validation + zero burn for the company. Big Pharma often waits for early efficacy from these studies… then moves fast. NT‑219 is sitting right on that trigger point.
0 · Reply
Purplepayday
Purplepayday Feb. 2 at 8:07 PM
$PPBT I’m very tired now…. Even that it have been downhill all the time..
0 · Reply
Purplepayday
Purplepayday Feb. 2 at 7:40 PM
$PPBT .. Where does Smitty find all that AI bullishness from… Because i can’t find it 🤷🏻‍♂️
0 · Reply
St0ckPwn
St0ckPwn Feb. 2 at 7:35 PM
$PPBT Pepperidge farm remembers
0 · Reply
Purplepayday
Purplepayday Feb. 2 at 7:19 PM
$PPBT Yes… 16 % down since JPM Healthcare conference must be very Bullish…. If you want to avg down some more i guess👍
0 · Reply
Winorbust
Winorbust Feb. 2 at 7:12 PM
$PPBT @Purplepayday but didn’t that Smitty guy say institutions are loaded up? And all the crashing and reverse splits means the company is gearing up? I mean it goes against all known logic, but somewhere in that guys head it all makes sense
0 · Reply
Purplepayday
Purplepayday Feb. 2 at 6:32 PM
$PPBT wild how significant the selloff have been here since the JPM Healthcare conference…. Even from our institution holders 🤔🤷🏻‍♂️
0 · Reply
Smittysixty
Smittysixty Feb. 2 at 6:22 PM
$PPBT Wild how perfectly $PPBT’s pipeline lines up with the major themes coming out of then JPM Healthcare conference Keynotes basically said the future is: • Multi‑pathway cancer drugs • STAT3 targeting • Fixing the tumor microenvironment • Buying IND‑ready assets early PB checks every single box: • NT‑219 hits STAT3 + PD‑1 resistance • CM24 tackles CEACAM1 immune suppression • IM1240 is IND‑ready with clean tox • NT‑219 + CM24 both sit squarely in the Phase‑2 M&A zone JPM’s themes and PB’s pipeline aren’t just aligned — they’re almost a 1:1 match.
0 · Reply
LuckyBoy27
LuckyBoy27 Feb. 2 at 4:26 PM
$PPBT what a pathetic POS management. What the hell they are doing nothing.
1 · Reply